German eye clinic group EuroEyes sets sights on US$90 million IPO in Hong Kong as investor sentiment starts to make a comeback
- It is the latest in a series of initial public offerings (IPOs) returning to the city after confidence was damaged by the political crisis
Germany-based EuroEyes International Eye Clinic announced on Friday that it would seek to list its shares in Hong Kong for up to HK$700 million (US$89 million), the latest in a series of initial public offerings (IPOs) returning to the city as the financial hub endures its worst political crisis.
Investor sentiment has improved in September after trade tensions between the US and China eased somewhat and Hong Kong Chief Executive Carrie Lam Yuet-ngor formally withdrew the extradition bill which had sparked months of protests in the city.
The improved appetite among investors has made companies more comfortable coming back to the market for new listings.
“We think Hong Kong is still the perfect international gateway into China,” said Jørn Slot Jørgensen, chairman and chief executive officer of EuroEyes, one of Germany’s largest independent eye surgery groups and the first foreign eye clinic group to open in China, in 2012.
Our future and growth will take place in China, and therefore we felt it very natural that we get listed in Hong Kong
EuroEyes provides specialised corrective surgery for refractive vision errors, with operations in Germany, Denmark and China.